[
    [
        {
            "time": "",
            "original_text": "瑞德西韦三期临床研究开展 两家上市公司参与",
            "features": {
                "keywords": [
                    "瑞德西韦",
                    "三期临床",
                    "上市公司",
                    "泰格医药",
                    "迪安诊断"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "瑞德西韦三期临床研究开展 两家上市公司参与",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "瑞德西韦三期临床研究开展 泰格医药、迪安诊断参与",
            "features": {
                "keywords": [
                    "瑞德西韦",
                    "三期临床",
                    "泰格医药",
                    "迪安诊断"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "瑞德西韦三期临床研究开展 泰格医药、迪安诊断参与",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]